Andson Biotech
PrivateLast Round
Seed
Oct 21, 2025
Total Funding Raised
$8.95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Andson Biotech operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Seed round in October 2025.
Andson Biotech is a biotechnology tools company that develops microfluidic-based hardware platforms to streamline and accelerate mass spectrometry workflows for the biopharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Andson Biotech Comparables
Compare Andson Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 908 Devices Inc. | 74% | |
| CellFE | 73% | |
| Thermo Fisher Scientific Inc. | 71% |
For institutional investors. Book with your work email.
Andson Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 21, 2025 | ||||
| Seed | Apr 30, 2024 | ||||
| Accelerator | Dec 15, 2022 | ||||
| Accelerator | Jan 10, 2022 | ||||
| Grant | Aug 20, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Andson Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Seed |
| McKesson Ventures | Accelerator |
| Georgia Research Alliance | Seed |
| Northpond Ventures | Accelerator |
| Merck Digital Sciences Studio | Seed |
| Y Combinator | Seed, Accelerator |
| BioTools Innovator | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Grew 18% QoQ from 17 to 20 employees.
- Apr 16, 2026
Monthly visitors grew 110% MoM, reaching 2K.
For institutional investors. Book with your work email.
Andson Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Andson Biotech's valuation, stock price, and market status.
Is Andson Biotech a public or private company?
Andson Biotech is a private company.
What is the current stock price of Andson Biotech?
Andson Biotech is a private company, so its shares have no public market price. Caplight tracks Andson Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Andson Biotech worth (valuation)?
Valuation information for Andson Biotech is not publicly available.
Can I buy Andson Biotech stock?
Andson Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Andson Biotech's last funding round?
Andson Biotech's most recent funding round was Seed on October 21, 2025.
Who are the main investors in Andson Biotech?
Key investors in Andson Biotech include Y Combinator.
Will Andson Biotech IPO soon?
No public IPO plans have been announced for Andson Biotech.
How can I track Andson Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Andson Biotech's shares on secondary markets.